UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Rimonabant improves cholesterol, insulin resistance and markers of non-alcoholic fatty liver in morbidly obese patients: a retrospective cohort study

Wierzbicki, AS; Pendleton, S; McMahon, Z; Dar, A; Oben, J; Crook, MA; Botha, AJ; (2011) Rimonabant improves cholesterol, insulin resistance and markers of non-alcoholic fatty liver in morbidly obese patients: a retrospective cohort study. INT J CLIN PRACT , 65 (6) 713 - 715. 10.1111/j.1742-1241.2011.02683.x.

Full text not available from this repository.


Type:Article
Title:Rimonabant improves cholesterol, insulin resistance and markers of non-alcoholic fatty liver in morbidly obese patients: a retrospective cohort study
DOI:10.1111/j.1742-1241.2011.02683.x

Archive Staff Only: edit this record